Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure a swift roll out of new drugs to treat dementia should they become approved and available.
The Government wants all patients to benefit from rapid access to safe and effective new medicines in a way that is affordable and represents value to the National Health Service. The National Institute for Health and Care Excellence (NICE) will work closely with the Medicines and Healthcare products Regulatory Agency and the manufacturers and will aim to issue recommendations for the NHS on new licensed medicines for dementia as close as possible to licensing.
NHS England stands ready to ensure patients can benefit from any new licensed and NICE approved disease modifying treatment for dementia as quickly as possible.